Intravenous fluid therapy successfully prevents renal injury by gemcitabine in patients with pancreatic cancer

Shigeru B.H. Ko, Sakiko Azuma, Kaori Kamimura, Hidemi Goto, Naohiko Anzai, Akiko Yamamoto, Hiroshi Ishiguro, Nobumasa Mizuno

Research output: Contribution to journalLetter

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)784-787
Number of pages4
JournalPancreas
Volume40
Issue number5
DOIs
Publication statusPublished - 2011 Jul

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Hepatology
  • Endocrinology

Cite this

Ko, S. B. H., Azuma, S., Kamimura, K., Goto, H., Anzai, N., Yamamoto, A., Ishiguro, H., & Mizuno, N. (2011). Intravenous fluid therapy successfully prevents renal injury by gemcitabine in patients with pancreatic cancer. Pancreas, 40(5), 784-787. https://doi.org/10.1097/MPA.0b013e318214efce